jaktinib
Showing 1 - 7 of 7
Ankylosing Spondylitis Trial in Shanghai (Jaktinib)
Not yet recruiting
- Ankylosing Spondylitis
- Jaktinib
-
Shanghai, Shanghai, ChinaRenji Hospital
May 6, 2023
Ankylosing Spondylitis Trial in Shanghai (Jaktinib, Placebo)
Not yet recruiting
- Ankylosing Spondylitis
- Jaktinib
- Placebo
-
Shanghai, Shanghai, ChinaRenJi Hospital
May 6, 2023
Myelofibrosis Trial in Hangzhou (Jaktinib, Placebo to match Hydroxycarbamide, Hydroxycarbamide Tablets)
Recruiting
- Myelofibrosis
- Jaktinib
- +3 more
-
Hangzhou, Zhejiang, ChinaThe First Affiliated Hospital of Medical School of Zhejiang Univ
Nov 28, 2022
COVID-19 Pneumonia Trial in Hangzhou (Jaktinib, Placebo)
Not yet recruiting
- COVID-19 Pneumonia
- Jaktinib
- Placebo
-
Hangzhou, Zhejiang, ChinaThe First Affiliated Hospital of College of Medicine Zhejiang Un
Jan 12, 2023
Moderate-to-Severe Plaque Psoriasis Trial in Shenyang (Jaktinib, Placebo)
Recruiting
- Moderate-to-Severe Plaque Psoriasis
- Jaktinib
- Placebo
-
Shenyang, Liaoning, ChinaThe First Affiliated Hospital of China Medical University
Nov 28, 2022
Alopecia Areata Trial (Jaktinib)
Not yet recruiting
- Alopecia Areata
- Jaktinib
- (no location specified)
Feb 22, 2022
MDS, Myeloproliferative Tumors, Myelofibrosis Trial (Jaktinib, azacitidine)
Not yet recruiting
- Myelodysplastic Syndromes
- +2 more
- Jaktinib
- azacitidine
- (no location specified)
Nov 29, 2021